Yes we have IP and licencing rights to sell. All will be more clear after results but if theyre inline with ph2a we may be seeing a commercial approval which the market would factor in the sales from at least six months before it happens.
the broker report put us around $1B in partner payment value, and theres no % royalty on that, thats all for us, and you'd expect to get most of that before receipt of patients sales.
PER - Megathread, page-357
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
